Abstract
Multiple sclerosis (MS) is an inflammatory, demyelinating disorder of the central nervous system that develops in genetically susceptible individuals. The majority of the MS-associated gene variants are located in genetic regions with importance for T-cell differentiation. Vitamin D is a potent immunomodulator, and vitamin D deficiency has been suggested to be associated with increased MS disease susceptibility and activity. In CD4+ T cells, we have analyzed in vitro vitamin D responsiveness of genes that contain an MS-associated single-nucleotide polymorphism (SNP) and with one or more vitamin D response elements in their regulatory regions. We identify IL2RA and TAGAP as novel vitamin D target genes. The vitamin D response is observed in samples from both MS patients and controls, and is not dependent on the genotype of MS-associated SNPs in the respective genes.
Original language | English |
---|---|
Pages (from-to) | 118-127 |
Number of pages | 10 |
Journal | Genes and Immunity |
Volume | 17 |
Issue number | 2 |
DOIs | |
Publication status | Published - Mar 2016 |
Externally published | Yes |
Bibliographical note
Funding Information:TB has received an unrestricted grant for running expenses in this project from Biogen Idec Norway AS, ISL has received unrestricted grant for salary expenses from Novartis Norway AS and TH has received research grants from Merck Serono.
Publisher Copyright:
© 2016 Macmillan Publishers Limited.